Archive: 02/06/2014
Clinical trial shows drug combination may be effective in recurrent ovarian cancer
Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago today. This is the ...
Jun 2, 2014
Studies reveal new strategies to improve quality of life
Key studies released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) identify new strategies for easing the short- and long-term effects of cancer therapy and improving the quality of ...
Jun 2, 2014
Early steps toward personalized fitness: Interval training may benefit men more than women
When it comes to reaping benefits of sprint interval training, it appears that men have won the battle of the sexes, if just barely. According to new research published in the June 2014 issue of The FASEB Journal, men create ...
Jun 2, 2014
Enzyme used in antidepressants could help researchers develop prostate cancer treatments
An international team of scientists including researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the University of Southern California found that an enzyme commonly used as a target for antidepressants ...
Jun 2, 2014
Common cholesterol drug greatly alters inflammatory response to common cold
Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in the June 2014 issue of the Journal of Leukocyte Biology, researchers ...
Jun 2, 2014
Why some experimental forms of 'The Pill for Males' will never rise to the occasion
It appears that "The Pill" for men will have to wait a while longer. A new research report published in the June 2014 issue of The FASEB Journal involving mice, shows that a previously developed male hormonal oral contraceptive ...
Jun 2, 2014